4.2 Interpretation of findings in relation to previous publications and implications for future research
inflammation, Aetiopathogenesis
INFLAMMATION, VIRUS, COVID-19 PNEUMONIA, PATHOPHYSIOLOGY
The current study signifies the efficacy of homoeopathic treatment as an adjuvant therapy for moderate to severe cases of COVID-19 who were admitted to an ICU setup. There exists a previous study which included mild to severe cases of COVID-19 where use of individualised Homoeopathic treatment as an adjuvant therapy, signifies better clinical outcome with early recovery [The effect of Arnica montana as a remedy for clinical conditions belonging to the respiratory system should be evaluated further, as it is limitedly known in this sphere, while commonly regarded as an injury & inflammation specific remedy the pathophysiology of lung involved in COVID-19 pneumonia also shows the same features. Aetiopathogenesis of Bryonia alba, Tuberculinum bovinum, and Phosphorus in resolving the consolidation in the lungs is well mentioned in source book of Homoeopathic therapeutics along with few other additional findings were observed in view of COVID-19 pathophysiology. The results of the study have shown the efficacy of treating COVID-19 patients in an integrated mode, and more rigorous, as well as pragmatic trials can add to the generalizability of the findings on the wider population. Future studies may be planned as double-blind to avoid experimenter biases.Further, mutation of the virus, change in severity of Covid since this study was conducted, availability of more clearly defined treatment protocols in standard of care (conventional treatment) and large portions of the global population now being vaccinated may affect the external validity of the results of this study.